リンパ内皮の分岐鎖アミノ酸カタボリック欠陥は心臓のリンパ整合性を弱め,HFpEFを誘発する
Xiong Guo1, Chong Huang1, Ling Zhang1
1Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an, China (X.G., C.H., L.Z., G.H., X.C., F.S., T.L., Z.C., C.L., Y.G., W.Y., Y.X., S.W., H.L., Z. Liu, Z. Lin, X.W., Z.W., F.Z., L.T.).
Circulation
|April 1, 2025
まとめ
リンパ内皮細胞 (LEC) の欠陥のある分岐鎖アミノ酸 (BCAA) 代謝に関連した心臓リンパ機能障害は,保存されたエジェクション分数 (HFpEF) の心不全に大きく寄与する. BCAAの分解とリンパの整合性を回復することは,HFpEFに対する潜在的な治療方法を提供します.
科学分野:
- 心血管生物学
- リンパ系の研究
- 代謝 疾患 の 仕組み
背景:
- 心臓機能不全の最も一般的な形態は 発射分数保存 (HFpEF) であるが,有効な治療法はまだ見つかっていない.
- 心臓リンパ系は心臓の健康に不可欠ですが,HFpEFにおけるその役割は十分に理解されていません.
研究 の 目的:
- HFpEFの心臓リンパ系の変化を調査する.
- HFpEFのリンパ機能障害の背後にあるメカニズムを解明する.
- 心臓のリンパ系を標的とした 治療戦略を探る
主な方法:
- HFpEFとヒトのHFpEFのマウスモデルにおける心臓リンパ系構造と機能の分析
- 遺伝子工学によるマウスモデル,高度な細胞,分子技術を活用した.
- リンパ系内皮細胞 (LEC) での分岐鎖アミノ酸 (BCAA) 代謝とその関連酵素の役割を調査した.
主要な成果:
- リンパ内皮細胞 (LEC) の密度が低下し,液体の排水が低下したなど,心臓リンパ系における構造的および機能的欠陥と関連していた.
- HFpEFにおける重要な代謝シグネチャーとして,LECにおける欠陥BCAAの代謝が確認された.
- VEGFC療法によるリンパ血管新生の回復またはBCAAの分解の強化により,リンパの整合性が改善され,HFpEFが軽減されました.
- VEGFR3の分解を引き起こし,リンパ血管新生を阻害した.
結論:
- LECにおけるBCAAの分解の障害によって引き起こされる心臓リンパ機能障害は,HFpEFの病原性における重要な要因である.
- BCAAの分解は,リンパ系生物学と心臓リンパ系完全性の維持に不可欠です.
- HFpEFに対する有望な治療法である.
関連する概念動画
Pathophysiology of Heart Failure
1.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
Imbalances in Cardiac Output
1.2K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.2K
Lymphatic Vessels and Lymph Transport
1.8K
Lymphatic vessels, known as lymphatics, are crucial in transporting lymph from peripheral tissues to our venous system. This process begins with lymph entering through tiny capillaries that branch through tissues. These capillaries have unique features such as larger diameters, thinner walls, and a distinctive one-way valve system formed by overlapping endothelial cells.
This one-way system allows fluids, solutes, and even pathogens to enter but prevents their return to the intercellular...
This one-way system allows fluids, solutes, and even pathogens to enter but prevents their return to the intercellular...
1.8K
Lysosomal Hydrolases
3.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.7K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
331
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
331
Pathophysiology of Cardiac Performance
490
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
490


